Stamler J, Neaton JD. The multiple risk factor intervention trial (MRFIT) – importance then and now. JAMA. 2008;300(11):1343–5.
Article
CAS
PubMed
Google Scholar
Kannel WB, Wolf PA. Framingham study insights on the hazards of elevated blood pressure. JAMA. 2008;300(21):2545–7.
Article
CAS
PubMed
Google Scholar
King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam elderly study. Eur J Epidemiol. 1991;7(4):403–22.
Article
CAS
PubMed
Google Scholar
Prabhakaran D, Anand S, Watkins D, et al. Cardiovascular, respiratory, and related disorders: key messages from disease control priorities, 3rd edition. Lancet. 2018;391(10126):1224–36.
Article
PubMed
Google Scholar
Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. 2015. Mental, Neurological, and Substance Use Disorders. Disease Control Priorities, third edition, volume 4. Washington, DC: World Bank. License: Creative Commons Attribution CC BY 3.0 IGO. https://doi.org/10.1596/978-1-4648-0426-7.
Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277(16):1293–8.
Article
CAS
PubMed
Google Scholar
Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American study of kidney disease (AASK) trial. AASK Pilot Study Investigators. Kidney Int. 1997;51(1):244–52.
Article
CAS
PubMed
Google Scholar
Sorof JM, Hawkins EP, Brewer ED, Boydstun II, Kale AS, Powell DR. Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol. 1998;12(9):764–8.
Article
CAS
PubMed
Google Scholar
Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tzur S, Rosset S, Shemer R, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010;128(3):345–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomson R, Genovese G, Canon C, et al. Evolution of the primate trypanolytic factor APOL1. Proc Natl Acad Sci U S A. 2014;111(20):E2130–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Freedman BI, Moxey-Mims M. The APOL1 long-term kidney transplantation outcomes network – APOLLO. Clin J Am Soc Nephrol. 2018;13(6):940–2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anand S, Zheng Y, Montez-Rath ME, et al. Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries. BMJ Glob Health. 2017;2(4):e000453.
Article
PubMed
PubMed Central
Google Scholar
Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22(10):1795–803.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mercader JM, Florez JC. The genetic basis of type 2 diabetes in Hispanics and Latin Americans: challenges and opportunities. Front Public Health. 2017;5:329.
Article
PubMed
PubMed Central
Google Scholar
Consortium STD, Williams AL, Jacobs SB, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014;506(7486):97–101.
Article
CAS
Google Scholar
Nair AK, Baier LJ. Complex genetics of type 2 diabetes and effect size: what have we learned from isolated populations? Rev Diabet Stud. 2015;12(3–4):299–319.
Article
PubMed
PubMed Central
Google Scholar
Staimez LR, Deepa M, Ali MK, Mohan V, Hanson RL, Narayan KMV. Tale of two Indians: heterogeneity in type 2 diabetes pathophysiology. Diabetes Metab Res Rev. 2019;35:e3192.
Article
PubMed
PubMed Central
Google Scholar
Vartiainen E, Du DJ, Marks JS, et al. Mortality, cardiovascular risk factors, and diet in China, Finland, and the United States. Public Health Rep. 1991;106(1):41–6.
CAS
PubMed
PubMed Central
Google Scholar
Ueshima H, Zhang XH, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens. 2000;14(10–11):765–9.
Article
CAS
PubMed
Google Scholar
Corsi DJ, Subramanian SV, Chow CK, et al. Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J. 2013;166(4):636–46 e4.
Article
PubMed
Google Scholar
Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27.
Article
CAS
PubMed
Google Scholar
Caplin B, Yang CW, Anand S, et al. The International Society of Nephrology's international Consortium of collaborators on chronic kidney disease of unknown etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset. Kidney Int. 2019;95(1):4–10.
Article
PubMed
Google Scholar
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
Article
CAS
PubMed
Google Scholar
Karthikeyan G, Teo KK, Islam S, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study. J Am Coll Cardiol. 2009;53(3):244–53.
Article
CAS
PubMed
Google Scholar
Association of Physicians of India. Indian guidelines on hypertension (I.G.H.) - III. 2013. J Assoc Physicians India. 2013;61(2 Suppl):6–36.
Google Scholar
Gupta AK, Poulter NR, Dobson J, et al. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial. Am J Hypertens. 2010;23(9):1023–30.
Article
CAS
PubMed
Google Scholar
Ojji DB, Mayosi B, Francis V, et al. Comparison of dual therapies for lowering blood pressure in black Africans. N Engl J Med. 2019;380(25):2429–39.
Article
PubMed
Google Scholar
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288(23):2981–97.
Article
Google Scholar
Kim YG, Hahn S, Oh TJ, Kwak SH, Park KS, Cho YM. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia. 2013;56(4):696–708.
Article
CAS
PubMed
Google Scholar
Boyko EJ, Gerstein HC, Mohan V, et al. Effects of ethnicity on diabetes incidence and prevention: results of the diabetes REduction assessment with ramipril and rosiglitazone medication (DREAM) trial. Diabet Med. 2010;27(11):1226–32.
Article
CAS
PubMed
Google Scholar
Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644–57.
Article
CAS
PubMed
Google Scholar
Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–28.
Article
CAS
PubMed
Google Scholar
Prabhakaran D, Ajay VS, Tandon N. Strategic opportunities for leveraging low-cost, high-impact technological innovations to promote cardiovascular health in India. Ethn Dis. 2019;29(Suppl 1):145–52.
Article
PubMed
PubMed Central
Google Scholar
Jeet G, Thakur JS, Prinja S, Singh M. Community health workers for non-communicable diseases prevention and control in developing countries: evidence and implications. PLoS One. 2017;12(7):e0180640.
Article
PubMed
PubMed Central
CAS
Google Scholar
Alaofe H, Asaolu I, Ehiri J, et al. Community health workers in diabetes prevention and management in developing countries. Ann Glob Health. 2017;83(3–4):661–75.
Article
PubMed
Google Scholar
Schneider H, Okello D, Lehmann U. The global pendulum swing towards community health workers in low- and middle-income countries: a scoping review of trends, geographical distribution and programmatic orientations, 2005 to 2014. Hum Resour Health. 2016;14:65.
Article
PubMed
PubMed Central
Google Scholar
Prabhakaran D, Jaacks LM. Reflections from India on scaling up risk factor control for cardiovascular diseases to reach 1 billion adults. Circulation. 2019;139(1):4–6.
Article
PubMed
Google Scholar
Jamison DT, Alwan A, Mock CN, et al. Universal health coverage and intersectoral action for health: key messages from disease control priorities, 3rd edition. Lancet. 2018;391(10125):1108–20.
Article
PubMed
Google Scholar
Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205–23.
Article
PubMed
Google Scholar
Lima DF, Piovani VGS, Lima LA. Recreational soccer practice among adults, in Brazilian capitals, 2011–2015. Epidemiol Serv Saude. 2018;27(2):e2017284.
PubMed
Google Scholar
Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract. 2005;18(6):491–519.
Article
PubMed
Google Scholar
Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126–40.
Article
CAS
PubMed
PubMed Central
Google Scholar